Antiepileptic drugs and neurocognitive development

作者:Klein Pavel*; Mathews Gregory C
来源:Neurology, 2014, 82(3): 194-195.
DOI:10.1212/WNL.0000000000000044

摘要

In the current issue of Neurology (R), Shallcross et al.,(1) in a prospective observational study, compared cognitive and language skills of children born to women with epilepsy exposed in utero to levetiracetam (LEV, n = 53) or sodium valproate (VPA, n = 44), recruited from the UK Epilepsy Pregnancy Registry, and control children born to mothers without epilepsy or medication exposure during pregnancy (n = 133). Children were evaluated at the age of 36-54 months, building on previous findings at 24 months of age. The authors found no difference between LEV-exposed and control children. VPA-exposed children had lower scores on tests of gross motor skills, comprehension, and expressive language abilities than LEV-exposed children. The authors conclude that in utero exposure to VPA, but not LEV, is associated with neurodevelopmental deficits of motor and language abilities.

  • 出版日期2014-1-21

全文